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Several studies have reported radioprotective, antimutagenic, anti-infl ammatory, antinociceptive, and 
anticancer effects of bee venom both in the cell and the whole organism. The aim of this study was to 
assess the effects of a single high dose of 100 µg mL-1 of whole bee venom in human lymphocytes in 
vitro over a variety of time spans (from 10 min to 24 h). After the treatment, we used the comet assay and 
micronucleus test to see the effect of bee venom on the cell. The comet assay confi rmed that the venom 
damaged the DNA molecule. Tail length, tail intensity, tail moment showed a signifi cant increase (P<0.05). 
The percentage of long-tailed nuclei (LTN) with the tail length exceeding the 95th percentile also increased 
in a time-dependent manner. The micronucleus parameters (number of micronuclei, nucleoplasmic bridges, 
and nuclear buds) also showed a signifi cant time-dependent increase (P<0.05). This research indicates that 
high concentrations of bee venom can lead to cellular instability. Further research is needed to understand 
the mechanism of action of bee venom and its components in human cells and to see if this natural product 
may fi nd application in medicine.
KEY WORDS: comet assay, DNA damage, in vitro studies, melittin, micronucleus test 
Garaj-Vrhovac V, Gajski G. CYTOGENETIC STATUS AFTER EXPOSURE TO BEE VENOM
Arh Hig Rada Toksikol 2009;60:27-34
Over the past few years, a number of studies 
were published on the benefi cial role of bee venom 
including  radioprotective (1), antimutagenic (2), anti-
infl ammatory (3), antinociceptive (4), and anticancer 
activities (5). In addition, recent studies reported 
several effects of bee venom such as induction of 
apoptosis and necrosis, and effects on proliferation, 
cytotoxicity, and growth inhibition of different types 
of cancer cells (6-11).
Bee venom is a very complex mixture of at least 
18 active components including peptides, enzymes, 
and amines, which have a wide variety of properties. 
The major components of bee venom are melittin, 
phospholipase A
2
, apamin, adolapin, histamine, 
catecholamines, and mast cell degranulating peptide 
(12, 13). Melittin is the main component and 
the principal toxin in bee venom, and comprises 
around 50 % of the dry weight of the venom (14, 
15). This protein is a highly basic polypeptide with 
molecular weight of 2850 Da and a known amino 
acid sequence consisting of 26 amino acid residues 
(16, 17). Melittin is mostly hydrophobic, but does 
have a hydrophilic sequence near the C-terminus 
(18). It is known that melittin affects erythrocytes, 
leukocytes, thrombocytes, and many pharmacological 
systems (19). It is also known to damage the cell 
membrane enzyme system and that it possesses lytic 
properties, probably due to its ability to insert itself 
into phospholipid layers (15, 19).
A combination of cytogenetic methods may 
improve assessment of the cell status after exposure to 
different types of natural compounds. These methods 
make it possible to evaluate cytotoxic effects even 
at the level of primary DNA damage or to establish 
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the dynamics of its repair after exposure to cytotoxic 
and/or genotoxic agents.
The comet assay and micronucleus test are fast and 
effective tools for assessing the primary toxic effects 
induced by chemical and physical agents (20-22). 
The comet assay is a rapid, sensitive, and relatively 
simple method for detecting DNA damage at the 
level of individual cell. It combines the simplicity of 
biochemical techniques for detecting DNA single-
strand breaks, alkali labile sites, and cross-linking, 
with the single-cell approach typical of cytogenetic 
assays (23). 
With its simple scoring, the micronucleus test 
has been an attractive cytogenetic tool for assessing 
exposure to cytotoxic and/or genotoxic agents. 
Micronucleus test parameters are considered effective 
biomarkers of processes associated with the aneugenic 
and clastogenic damage (24).
The aim of this in vitro study was to see the 
effects of a high concentration of bee venom on the 
DNA and on the cell. To do this, we exposed human 
peripheral blood lymphocytes to bee venom from 10 
minutes to 24 hours. The concentration of bee venom 




Human blood was obtained from a healthy male 
donor (26 years of age). The donor had not been 
exposed to ionising radiation for diagnostic or 
therapeutic purposes or to known genotoxic chemicals 
for a year before blood sampling. Venous blood was 
collected under sterile conditions in heparinised 
vacutainer tubes (Becton Dickinson, NJ, USA) 
containing lithium heparin as anticoagulant. After 
collection, blood was divided into a large number of 
samples. 
Bee venom
Lyophilised whole bee venom was purchased 
from Sigma Chemical Co. Just before the beginning 
of the experiment, bee venom was dissolved in sterile 
redistilled water at 25 °C, and centrifuged at 12,000 
rpm for 10 min to remove insoluble materials. The 
aliquote of bee venom water solution was added to 
lymphocyte cultures to make the fi nal concentration 
of 100 µg mL-1.
Experimental design
All experiments were conducted on the same 
blood sample treated with bee venom in the fi nal 
concentration of 100 µg mL-1 for 10 min, 30 min, 
1 h, 6 h, and 24 h. Whole blood and cell cultures in 
Euroclone medium were incubated in vitro at 37 °C 
in a humifi ed atmosphere with 5.0 % CO
2
 (Heraeus 
Heracell 240 incubator, Langenselbold, Germany). 
After the treatment, all experiments were conducted 
according to the standard protocols.
Cell viability test
Cell viability and necrosis were determined 
by differential staining with acridine orange and 
ethidium bromide and by fl uorescence microscopy 
(25). Peripheral blood lymphocytes were exposed 
to whole bee venom over different lengths of time. 
Lymphocytes were isolated using a modifi ed Ficoll-
Histopaque centrifugation method (26). The slides 
were prepared using 200 µL of human peripheral blood 
lymphocytes and 2 µL of stain (acridine orange and 
ethidium bromide, both diluted in phosphate-buffered 
saline; PBS). A total of 100 cells per repetition were 
examined with an Olympus AX-70 microscope, using 
a 60x objective and fl uorescence fi lters of 515 nm to 
560 nm. The cells were divided in two categories: a) 
live cells with a functional membrane, with uniform 
green staining of the nucleus and b) necrotic cells with 
uniform orange staining of the nucleus.
Measurement of lymphocyte DNA damage with the 
alkaline comet assay
The comet assay was performed as previously 
described by Singh et al. (23, 27) with minor 
modifi cations. Five microlitres of whole blood were 
carefully re-suspended in 100 µL of  0.5 % low melting 
point (LMP) agarose, layered onto microscope slides 
that had been pre-coated with 300 µL of 0.5 % normal 
melting point (NMP) agarose. Coverslips were placed 
on the slides, and the agarose was allowed to solidify 
for 10 min on ice. After removal of the coverslips, 
100 µl of 0.5 % LMP were again spread over the 
slides, which were then covered with coverslips and 
kept for another 10 min on ice. The coverslips were 
removed and the slides immersed in cold fresh lysing 
solution (2.5 mol L-1 NaCl, 100 mmol L-1 Na
2
EDTA, 
10 mmol L-1 Tris, 10 % DMSO, 1 % Triton X-100, and 
1 % laurosylsarcosinate, pH 10). To avoid additional 
DNA damage, these procedures were performed under 
dim light. Afterwards, the slides were placed for 
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20 min in a horizontal gel electrophoresis tank fi lled 
with cold electrophoresis buffer (1 mmol L-1 Na
2
EDTA 
and 300 mmol L-1 NaOH, pH 13.5) to allow DNA to 
unwind. Electrophoresis was then performed in the 
same buffer for 20 min at 25 V and 300 mA. Both 
the unwinding and electrophoresis were performed 
in an ice bath. After electrophoresis, the slides were 
neutralised three times for 5 min with 0.4 mol L-1 Tris 
(pH 7.5). The slides were stained with 20 µg mL-1 
EtBr (ethidium bromide) just before analysis. Finally, 
the slides were examined under a Zeiss fl uorescence 
microscope (250x) equipped with a (515 to 560) nm 
excitation fi lter and a 590 nm barrier fi lter. Cell images 
were analysed with a computerised image analysis 
system Comet Assay II (Perceptive Instruments Ltd., 
UK). One hundred randomly selected cells were 
analysed per sample. To quantify DNA damage, the 
following comet parameters were evaluated: tail length 
(µm), tail intensity (% DNA), and tail moment. Tail 
length (i.e. the length of DNA migration) is directly 
related to the DNA fragment size and is expressed in 
micrometers. It was calculated from the centre of the 
cell. Tail intensity and tail moment were calculated 
by the computer. For each sample, we also analysed 
the frequency of long-tailed nuclei (LTN) with the tail 
length exceeding the 95th percentile of control (28). 
The analysis did not include the edges and damaged 
parts of the gel as well as debris, superimposed 
comets, and comets without distinct head (“clouds”, 
“hedgehogs”, or “ghost cells”).
Micronucleus test in cultured human lymphocytes
The micronucleus test was performed following 
the guidelines described by Fenech and Morley (24) 
and Fenech et al. (29). Whole blood was added to 
Euroclone medium (chromosome kit P, Euroclone, 
Italy). Human lymphocytes were incubated at 
37 ºC for 72 h. Cytocalasin-B was added to arrest 
cytokinesis at 44 h after the start of the culture. The 
fi nal concentration of cytocalasin B in lymphocyte 
cultures was 3 µg mL-1. The cells were then harvested 
by centrifugation (1000 rpm, 10 min), and the 
pellet was re-suspended in a hypotonic solution of 
0.075 mol L-1 KCI. The cells were re-centrifuged and 
fi xed three times in cold methanol:acetic acid (3:1). 
Slides were prepared by dropping and air-drying, and 
were stained with 5 % Giemsa (Sigma). One thousand 
binuclear lymphocytes were analysed to determine the 
frequency of micronuclei (MNs), their distribution per 
micronucleated cell, and the presence of nucleoplasmic 
bridges (NPBs) and nuclear buds (NBs). 
Statistical analysis
For the comet assay, each experimental set 
contained duplicated slides. The parameters (tail 
length, tail intensity, and tail moment) measured in 
the exposed and control groups were evaluated using 
a Statistica 5.0 package (StatSoft, Tulsa, USA). Each 
sample was characterised for the extent of DNA 
damage by considering the mean ± SD (standard 
deviation of the mean), median, and range of the comet 
parameters. In order to normalise distribution and to 
equalise the variances, a logarithmic transformation 
of data was applied. The log-transformed data were 
then used to make multiple comparisons between the 
groups by means of ANOVA. Post-hoc analysis of 
differences was done with the Scheffé test. As for the 
micronucleus test, the total number and distribution 
of micronuclei was analysed using the chi-square 
test. The level of statistical signifi cance was set at 
P<0.05.
Table 1  Baseline DNA damage for the comet parameters (tail length, tail intensity, and tail moment) in human peripheral blood 




Tail length / µm Tail intensity / % DNA Tail moment LTN 
% Min. Mean±SD Max. Median Min. Mean±SD Max. Median Min. Mean±SD Max. Median
10 min 10.90 12.85±1.21 16.67 12.82 0.00 1.02±1.98 15.27 0.45 0.00 0.12±0.23 1.76 0.05 10*
30 min 10.90 13.69±1.31* 17.95 13.46 0.00 0.98±1.75 11.30 0.38 0.00 0.12±0.21 1.23 0.05 27*
1 h 12.18 13.74±1.28* 17.95 13.46 0.00 1.15±1.71 10.80 0.40 0.00 0.14±0.20 1.32 0.05 26*
6 h 12,18 15.56±2.76* 21.15 15.38 0.00 3.73±4.51* 20.47 2.01 0.00 0.47±0.57* 2.62 0.27 57*
24 h 13.46 23.83±5.52* 33.97 24.36 0.20 17.59±9.35* 40.00 18.89 0.00 2.53±1.42* 5.90 2.69 95*
Control 10.90 12.68±0.81 14.10 12.82 0.00 0.87±1.13 5.68 0.45 0.00 0.10±0.12 0.59 0.05 0
* Statistically signifi cant increase in respect to control (P<0.05).
LTN = long-tailed nuclei
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The viability of the cells, as determined by 
acridine orange and ethidium bromide staining, using 
fl uorescence microscopy, was consistently above 79 % 
in all the exposed samples and above 95 % in control 
samples. This is considered to be in acceptable range 
for conducting the comet assay (30, 31).
Comet assay
The mean value ± SD of the comet tail lengths was 
(12.68±0.81) µm for the control sample. The mean ± 
SD for the bee venom (BV) treated samples ranged 
from (12.85±1.21) µm to (23.83±5.52) µm, depending 
Figure 1  Parameters of the comet assay (tail length, tail intensity and tail moment) expressed as mean values ± standard 
deviation measured in unexposed human peripheral blood lymphocytes (control) and those exposed to bee venom 
(100 µg mL-1) for different lengths of time. 
               *statistically signifi cant increase in respect to control (P<0.05).
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on the length of treatment. Mean tail intensity was 
(0.87±1.13) % DNA for the control sample and from 
(0.98±1.25) % DNA to (17.59±9.35) % DNA for the 
treated samples, depending on the length of treatment. 
Mean comet moment was (0.10±0.12) for the control 
sample and from (0.12±0.21) to (2.53±5.90) for the 
treated samples, depending on the length of treatment. 
All comets were classifi ed according to the threshold 
level for long-tailed nuclei (LTNs). The cut-off value 
in this study was 14.10 µm, and all comets with a 
greater tail length were considered LTN, and cells 
categorised as “damaged”. The percentage of LTNs 
ranged from 10 % to 95 %, depending on the length of 
treatment, whereas control samples has no LTNs.
Table 1 shows the basic statistics for the parameters 
of comet assay for different exposure lengths. 
According to the one-way ANOVA, tail length 
signifi cantly deviated from the normal distribution 
in cells exposed to bee venom for 30 min and over, 
whereas tail intensity and tail moment signifi cantly 
differed from controls in cells exposed for 6 h and 
over (Figure 1). The signifi cant differences observed 
for all three parameters were time dependent.
Micronucleus test
Table 2 summarises the frequency and distribution 
of micronuclei, nucleoplasmic bridges, and nuclear 
buds in the exposed and control groups of cells. The 
total number of micronuclei observed in binuclear 
peripheral blood lymphocytes of the exposed samples 
(ranging from 18 to 22) was signifi cantly (P<0.05) 
higher than in the control sample (2). The number 
of nucleoplasmic bridges (ranging from 12 to 16) 
and nuclear buds (ranging from 6 to 18) was also 
significantly (P<0.05) higher in samples treated 
with bee venom than in controls, which showed 
nucleoplasmic bridges or nuclear buds.
DISCUSSION AND CONCLUSION
The alkaline comet assay and the micronucleus 
test are the two most widely applicable techniques 
today for evaluation of cytogenetic alterations in cells 
exposed to physical and chemical agents.
Comet assay, also known as the single-cell gel 
electrophoresis, is a powerful tool for measuring DNA 
damage in eukaryotic cells. This technique has become 
one of the standards for assessing genome damage, 
with a variety applications in genotoxicity testing 
and fundamental research in DNA damage and repair 
(27). The comet assay detects primary DNA damage, 
and makes it possible to study the repair kinetics at 
the level of a single cell (32). There is a variety of 
possible modifi cations of the assay which facilitate the 
detection of single-strand DNA breaks, alkali-labile 
sites, double-strand DNA breaks, incomplete excision 
repair sites, and interstrand crosslinks (33). The comet 
assay can also be used to assess DNA fragmentation 
associated with cell death or apoptosis (34, 35).
In addition to the comet assay, another widely used 
assay is the micronucleus test which makes it possible 
to distinguish between clastogenic and aneugenic 
effects (24, 36). Micronuclei are an effective 
biomarker of diseases and processes associated with 
DNA damage. The cytokinesis-block micronucleus 
assay (CBMN) has solved the problem of variation in 
micronucleus frequency caused by alterations in the 
proportion of dividing cells which may occur when 
cells are exposed to genotoxic agents, by restricting 
the scoring of micronuclei to once-divided cells (31). 
In addition to measuring cytogenetic damage with 
the number and distribution of micronuclei, CBMN 
also detects nucleoplasmic bridges, and nuclear buds. 
Current evidence suggests that nucleoplasmic bridges 
derive from dicentric chromosomes in which the 
centromeres have been pulled to the opposite poles of 
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Table 2  Total number and distribution of micronuclei, nucleoplasmic bridges, and nuclear buds in human peripheral blood 







Nucleoplasmic bridges Nuclear buds
Without MNs 1 MN 2 MNs 1 NPB 2 NPBs 1 NB 2 NBs
1 979 18* 3 24* 13* - 6* 2
6 974 19* 7* 33* 16* 1 11* 1
24 978 22* - 22* 12* 1 18* 5
Control 998 2 - 2 - - - -
MN=micronucleus; NPB=nucleoplasmic bridge; NB=nuclear bud
* Statistically signifi cant increase in respect to control (P<0.05).
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the cell during the anaphase stage, and are therefore 
indicative of the DNA mis-repair, chromosome 
rearrangement, or telomere end-fusion. Nuclear 
buds arise from the elimination of amplifi ed DNA 
and possibly from the elimination of DNA repair 
complexes, and can therefore serve as markers of gene 
amplifi cation and altered gene dosage (29, 38-40).
Our alkaline comet assay showed that bee venom 
had a great impact on DNA stability, which was 
indicated by a statistically signifi cant, time-dependent 
increase in all comet parameters. It was the most 
obvious for the tail length, which signifi cantly deviated 
from the normal distribution with exposure length of 
30 minutes and higher. In addition, the difference in 
LTN was statistically signifi cant between the exposed 
and control samples, regardless of exposure length. 
These results are in accordance with our earlier 
study using bee venom in a concentration range from 
5 µg mL-1 to 100 µg mL-1 over different exposure 
times. In that study, we observed a statistically 
signifi cant increase in the tail length and tail moment 
in human lymphocytes treated with bee venom. These 
results showed that the extent of DNA damageI 
was time- and dose- dependent (41). Lee at al. (42) 
found a similar effect. In their study, an even lower 
concentration of whole bee venom induced single-
strand DNA breaks in human lymphocytes. The same 
was observed in another study by Ip et al. (43), where 
the comet assay also showed that bee venom induced 
DNA damage.
In addition to the comet parameters, we evaluated 
the cytogentic effect of bee venom using the 
micronucleus test. We noticed that all method 
parameters, the number of micronuclei, nucleoplasmic 
bridges, and nuclear buds, were signifi cantly higher 
for all lengths of exposure, and were also time-
dependent. We noticed that all method parameters, 
the number of micronuclei, nucleoplasmic bridges, 
and nuclear buds, were signifi cantly higher for all 
lengths of exposure and were also time-dependent. 
This was not the case with the study done by Lee et al. 
(42); they did notice a slight increase in micronucleus 
frequency, but their concentrations were much lower 
than ours. Additionally, in cells exposed for 24 h we 
observed the absence of cytoplasm, which can be due 
to melittin disruption of the cell membrane. Melittin 
is known to have effects on erythrocytes, leukocytes, 
thrombocytes, and many pharmacological systems 
(19). Moreover, as we were isolating the lymphocytes, 
we noticed that the separation medium (Histopaque) 
changed colour due to erythrocyte haemolysis.
All of the above effects of bee venom can largely be 
attributed to melittin, which accounts for over 50 % of 
its content. This peptide has a highly cytotoxic effect on 
different types of cells, mostly due to disruption of the 
cell membrane. Namely, melittin shares its amphipathic 
properties with a series of peptides that affect the cell 
membrane bilayer integrity, either by creating defects, 
disrupting it, or by forming pores (44). 
In conclusion, our results indicate that bee venom 
causes cellular instability. Further research is needed 
to for us to understand the mechanism of action of 
bee venom and its components on human cells, and 
to see if this natural product could fi nd application in 
medicine.
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Sažetak
PROCJENA CITOGENETIČKOG STATUSA U LJUDSKIM LIMFOCITIMA NAKON IZLOŽENOSTI 
VISOKIM KONCENTRACIJAMA PČELINJEG OTROVA U UVJETIMA IN VITRO
Cilj ovog istraživanja je procjena staničnog statusa ljudskih limfocita periferne krvi nakon tretmana visokom 
koncentracijom pčelinjeg otrova u in vitro uvjetima primjenom alkalnog kometnog testa i mikronukleusnog 
testa. Limfociti su bili izloženi pčelinjem otrovu u koncentraciji od 100 µg mL-1 u različitom vremenu (od 
10 min do 24 h). Rezultati kometnog testa upućuju na oštećenje molekule DNA povećanjem parametara 
kometnog testa (dužina repa, intenzitet repa i repni moment) te prisutnost limfocita s visokom učestalosti 
kometa s dugim repovima (LTN). U tim stanicama učestalost LTN premašuje 95 % ukupne raspodjele 
vrijednosti LTN dobivene za sve stanice kontrolnog uzorka. Parametri mikronukleusnog testa (broj 
mikronukleusa, nukleoplazmatski mostovi i nuklearni pupovi) također pokazuju značajan porast u odnosu 
na odgovarajući kontrolni uzorak (P<0,05). Rezultati dobiveni ovim tehnikama upućuju na to da pčelinji 
otrov u visokoj koncentraciji uzrokuje staničnu nestabilnost te na potrebu daljnjih istraživanja mehanizama 
djelovanja pčelinjeg otrova i njegovih sastavnica na ljudske stanice u svrhu primjene prirodnih spojeva 
posebice u medicinskoj praksi.
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